| 1E1G | A:125-228 | HUMAN PRION PROTEIN VARIANT M166V |
| 1E1J | A:125-228 | HUMAN PRION PROTEIN VARIANT M166V |
| 1E1P | A:125-228 | HUMAN PRION PROTEIN VARIANT S170N |
| 1E1S | A:125-228 | HUMAN PRION PROTEIN VARIANT S170N |
| 1E1U | A:125-228 | HUMAN PRION PROTEIN VARIANT R220K |
| 1E1W | A:125-228 | HUMAN PRION PROTEIN VARIANT R220K |
| 1FKC | A:125-231 | HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 |
| 1FO7 | A:125-231 | HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231 |
| 1H0L | A:119-230 | HUMAN PRION PROTEIN 121-230 M166C/E221C |
| 1HJM | A:125-228 | HUMAN PRION PROTEIN AT PH 7.0 |
| 1HJN | A:125-228 | HUMAN PRION PROTEIN AT PH 7.0 |
| 1I4M | A:119-226 | CRYSTAL STRUCTURE OF THE HUMAN PRION PROTEIN REVEALS A MECHANISM FOR OLIGOMERIZATION |
| 1LG4 | A:52-150 | NMR STRUCTURE OF THE HUMAN DOPPEL PROTEIN FRAGMENT 24-152 |
| 1QLX | A:125-228 | HUMAN PRION PROTEIN |
| 1QLZ | A:125-228 | HUMAN PRION PROTEIN |
| 1QM0 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 90-230 |
| 1QM1 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 90-230 |
| 1QM2 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 121-230 |
| 1QM3 | A:125-228 | HUMAN PRION PROTEIN FRAGMENT 121-230 |
| 2K1D | A:125-231 | NMR STUDIES OF A PATHOGENIC MUTANT (D178N) OF THE HUMAN PRION PROTEIN |
| 2W9E | A:125-223 | STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231 |
| 3HAF | A:120-225 | HUMAN PRION PROTEIN VARIANT V129 DOMAIN SWAPPED DIMER |
| 3HAK | A:125-227 | HUMAN PRION PROTEIN VARIANT V129 |
| 3HEQ | A:126-228; B:126-228 | HUMAN PRION PROTEIN VARIANT D178N WITH M129 |
| 3HER | A:125-226; B:126-227 | HUMAN PRION PROTEIN VARIANT F198S WITH V129 |
| 3HES | A:125-226; B:126-226 | HUMAN PRION PROTEIN VARIANT F198S WITH M129 |
| 3HJ5 | A:125-225; B:126-227 | HUMAN PRION PROTEIN VARIANT V129 DOMAIN SWAPPED DIMER |
| 3HJX | A:126-223 | HUMAN PRION PROTEIN VARIANT D178N WITH V129 |
)
)